RIGEL PHARMACEUTICALS, INC. Shareholders' Equity
RIGEL PHARMACEUTICALS, INC. (RIGL) had Shareholders' Equity of $425.42 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $425.42M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $399.90M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $391.48M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $117.61M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $425.42M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $399.90M 10-Q · filed 2026-08-04 |
| 2025-12-31 | $391.48M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $117.61M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $81.93M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $18.57M 10-Q · filed 2026-08-04 |
| 2024-12-31 | $3.29M 10-Q · filed 2026-08-04 |
| 2024-09-30 | -$14.64M 10-Q · filed 2025-11-04 |
| 2024-06-30 | -$29.91M 10-Q · filed 2025-11-04 |
| 2024-03-31 | -$31.67M 10-Q · filed 2025-11-04 |
| 2023-12-31 | -$28.64M 10-K · filed 2026-03-03 |
| 2023-09-30 | -$31.83M 10-Q · filed 2024-11-07 |
| 2023-06-30 | -$28.11M 10-Q · filed 2024-11-07 |
| 2023-03-31 | -$24.26M 10-Q · filed 2024-11-07 |
| 2022-12-31 | -$13.62M 10-K · filed 2026-03-03 |
| 2022-09-30 | -$19.83M 10-Q · filed 2023-11-07 |
| 2022-06-30 | -$3.68M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $6.80M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $30.37M 10-K · filed 2025-03-04 |
| 2021-09-30 | $49.67M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $68.11M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $78.30M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $34.03M 10-K · filed 2024-03-05 |
| 2020-09-30 | $50.95M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $63.21M 10-Q · filed 2021-11-02 |
| 2020-03-31 | $78.50M 10-Q · filed 2021-11-02 |
| 2019-12-31 | $53.81M 10-K · filed 2023-03-07 |
| 2019-09-30 | $68.91M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $78.29M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $95.31M 10-Q · filed 2020-11-05 |
| 2018-12-31 | $109.88M 10-K · filed 2022-03-01 |
| 2018-09-30 | $103.47M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $123.57M 10-Q · filed 2019-11-05 |
| 2018-03-31 | $79.81M 10-Q · filed 2019-11-05 |
| 2017-12-31 | $100.65M 10-K · filed 2021-03-02 |
| 2017-09-30 | $56.17M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $69.61M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $84.08M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $55.03M 10-K · filed 2020-02-27 |
| 2016-09-30 | $65.94M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $73.72M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $75.45M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $91.38M 10-K · filed 2019-02-28 |
| 2015-09-30 | $96.41M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $101.15M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $112.15M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $128.25M 10-K · filed 2018-03-06 |
| 2014-09-30 | $146.85M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $165.73M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $188.33M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $208.25M 10-K · filed 2017-03-07 |
| 2013-09-30 | $223.40M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $245.05M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $265.31M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $289.10M 10-K · filed 2016-03-08 |
| 2012-09-30 | $174.80M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $195.75M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $216.58M 10-Q · filed 2012-05-01 |
| 2011-12-31 | $236.15M 10-K · filed 2015-03-03 |
| 2011-09-30 | $257.96M 10-Q · filed 2011-11-01 |
| 2010-12-31 | $166.13M 10-K · filed 2014-03-04 |
| 2009-12-31 | $109.87M 10-K · filed 2013-03-05 |
| 2008-12-31 | $104.17M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |